Effect of rNA interference on Oatp3a1 gene expression on biological characteristics and immune factors of ovarian granulosa cells in rats with PCOS
- PMID: 32913539
- PMCID: PMC7476111
Effect of rNA interference on Oatp3a1 gene expression on biological characteristics and immune factors of ovarian granulosa cells in rats with PCOS
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrinal metabolic disease, and its pathogenesis has not yet been thoroughly studied. The purpose of this experiment was to investigate the effect of RNA interference on Oatp3a1 gene expression on the biological viability and immune factors of ovarian granulosa cells in rats with PCOS. First, rats were intragastrically administered 1 mg/kg letrozole to successfully construct PCOS model. Western blot, qRT-PCR, CCK8 and flow cytometry were used to detect the gene expression, immune factor protein expression, cell proliferation and apoptosis in ovarian granulosa cells transfected with siRNA Oatp3a1 in rats with PCOS, respectively. The results showed that follicle stimulating hormone receptor (FSHR) was located on the cell membrane of rat ovarian granulosa cells, and letrozole successfully induced PCOS rat model. In PCOS rat ovarian granulosa cells, the mRNA expression level of Oapta1 was higher than that in normal rat ovarian granulosa cells. At the same time, compared with the sham group, the protein expression of NF-κB, TGF-β1 and VEGF in si-Oatp3a1 group was significantly down-regulated (P < 0.05), and the cell proliferation rate was significantly decreased in si-Oatp3a1 group (P < 0.05) in comparison with the sham group. The apoptotic rate was increased obviously (P < 0.05), which was about 2.5 times that of the sham group. This indicates that in the ovarian granulosa cells of rats with PCOS, the interference of Oatp3a1 gene expression can significantly inhibit cell proliferation and promote apoptosis, while inhibiting the expression of immune factors TGF-β1 and VEGF can reduce the expression of NF-κB protein, thereby suppressing the activation of the NF-κB signaling pathway.
Keywords: NF-κB; Oatp3a1; ovarian granulosa cells in rats; polycystic ovary syndrome.
AJTR Copyright © 2020.
Conflict of interest statement
None.
Figures
Similar articles
-
Activation of TGF-β1/Smad3 signaling pathway inhibits the development of ovarian follicle in polycystic ovary syndrome by promoting apoptosis of granulosa cells.J Cell Physiol. 2019 Jul;234(7):11976-11985. doi: 10.1002/jcp.27854. Epub 2018 Dec 7. J Cell Physiol. 2019. PMID: 30536903
-
Expression of PGRMC1 in patients with polycystic ovary syndrome and its molecular mechanism for regulating ovarian granulosa cell apoptosis and glucolipid metabolism.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Apr 28;48(4):538-549. doi: 10.11817/j.issn.1672-7347.2023.220315. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 37385616 Free PMC article. Chinese, English.
-
Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.Syst Biol Reprod Med. 2017 Jun;63(3):150-161. doi: 10.1080/19396368.2017.1296046. Epub 2017 Mar 27. Syst Biol Reprod Med. 2017. PMID: 28345956
-
Inhibition of FoxO1 alleviates polycystic ovarian syndrome by reducing inflammation and the immune response.Funct Integr Genomics. 2024 Jan 8;24(1):6. doi: 10.1007/s10142-024-01284-4. Funct Integr Genomics. 2024. PMID: 38189995
-
The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.Hum Reprod. 2019 Dec 1;34(12):2467-2479. doi: 10.1093/humrep/dez214. Hum Reprod. 2019. PMID: 31735954
Cited by
-
Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis.Pharm Biol. 2023 Dec;61(1):878-885. doi: 10.1080/13880209.2023.2208636. Pharm Biol. 2023. PMID: 37272921 Free PMC article.
-
Knockdown of DNMT1 Induces SLCO3A1 to Promote Follicular Growth by Enhancing the Proliferation of Granulosa Cells in Mammals.Int J Mol Sci. 2024 Feb 20;25(5):2468. doi: 10.3390/ijms25052468. Int J Mol Sci. 2024. PMID: 38473715 Free PMC article.
-
Identification and validation of novel genes related to immune microenvironment in polycystic ovary syndrome.Medicine (Baltimore). 2024 Oct 25;103(43):e40229. doi: 10.1097/MD.0000000000040229. Medicine (Baltimore). 2024. PMID: 39470566 Free PMC article.
-
Discovery of immune-related diagnostic biomarkers and construction of diagnostic model in varies polycystic ovary syndrome.Arch Gynecol Obstet. 2022 Nov;306(5):1607-1615. doi: 10.1007/s00404-022-06686-y. Epub 2022 Jul 29. Arch Gynecol Obstet. 2022. PMID: 35904610
References
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25. - PubMed
-
- Bilo L, Meo R. Polycystic ovary syndrome in women using valproate: a review. Gynecol Endocrinol. 2008;24:562–570. - PubMed
-
- Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057. - PubMed
-
- Kumari R, Kanika J, Debasis D. Comparison of clinical outcomes in clomiphene citrate resistant infertile polycystic ovarian syndrome women after treatment with laparoscopic ovarian drilling (LOD) versus gonadotropins. Int J Reprod Contracept Obstet Gynecol. 2018;7:576–581.
LinkOut - more resources
Full Text Sources